Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects (Q39931959)

15 September 2017

Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects (English)

1 reference

15 September 2017

20

Jeffrey S Souris

1 reference

15 September 2017

Xiaoji Luo

1

1 reference

15 September 2017

Jin Chen

2

1 reference

15 September 2017

Wen-Xin Song

3

1 reference

15 September 2017

Ni Tang

4

1 reference

15 September 2017

Jinyong Luo

5

1 reference

15 September 2017

Zhong-Liang Deng

6

1 reference

15 September 2017

Katie A Sharff

7

1 reference

15 September 2017

Gary He

8

1 reference

15 September 2017

Yang Bi

9

1 reference

15 September 2017

Bai-Cheng He

10

1 reference

15 September 2017

Erwin Bennett

11

1 reference

15 September 2017

Jiayi Huang

12

1 reference

15 September 2017

Quan Kang

13

1 reference

15 September 2017

Wei Jiang

14

1 reference

15 September 2017

Yuxi Su

15

1 reference

15 September 2017

Gao-Hui Zhu

16

1 reference

15 September 2017

Hong Yin

17

1 reference

15 September 2017

Yun He

18

1 reference

15 September 2017

Yi Wang

19

1 reference

15 September 2017

Liang Chen

21

1 reference

15 September 2017

Guo-Wei Zuo

22

1 reference

15 September 2017

Anthony G Montag

23

1 reference

15 September 2017

Russell R Reid

24

1 reference

15 September 2017

Rex C Haydon

25

1 reference

15 September 2017

Hue H Luu

26

1 reference

15 September 2017

Tong-Chuan He

27

1 reference

15 September 2017

6 October 2008

1 reference

15 September 2017

Laboratory Investigation

1 reference

15 September 2017

88

1 reference

15 September 2017

12

1 reference

15 September 2017

1264-1277

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.2008.98

15 September 2017

0 references

cites work

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Mechanisms of sarcoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Orthopaedic implant-related sarcoma: a study of twelve cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Postirradiation sarcomas. A single-institution study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Second primary neoplasms in patients with retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Common musculoskeletal tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Wnt/beta-catenin signaling pathway as a novel cancer drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Wnt signaling and human diseases: what are the therapeutic implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Regulation of osteoblast formation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

The osteoblast: a sophisticated fibroblast under central surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Regulation of osteogenic differentiation during skeletal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Bone: formation by autoinduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Novel regulators of bone formation: molecular clones and activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Gene therapy for bone regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Mesenchymal stem cell features of Ewing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Prolonged culture of HOS 58 human osteosarcoma cells with 1,25-(OH)2-D3, TGF-beta, and dexamethasone reveals physiological regulation of alkaline phosphatase, dissociated osteocalcin gene expression, and protein synthesis and lack of mineralization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Mesenchymal stem cells: building blocks for molecular medicine in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the β-catenin signaling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Bone morphogenetic proteins in bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

A protocol for rapid generation of recombinant adenoviruses using the AdEasy system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Identification of c-MYC as a target of the APC pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

Osteosarcoma: pathology and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

1 reference

7 January 2021

Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

Transcriptional activation of p21 by vitamin D(3) or vitamin K(2) leads to differentiation of p53-deficient MG-63 osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

Induction of osteoblast differentiation indexes by PTHrP in MG-63 cells involves multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

Development and characterization of a conditionally immortalized human fetal osteoblastic cell line

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

Prognostic significance of bone morphogenetic activity in osteosarcoma tissue

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2008.98

7 January 2021

10.1038/LABINVEST.2008.98

Identifiers

DOI

1 reference

15 September 2017

1 reference